Sino Biopharmaceutical Limited (SBHMY)

USD 8.34

(0.0%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 63.6 Billion 64.06 Billion 60.54 Billion 47.21 Billion 58.29 Billion 49.78 Billion
Total Current Assets 23.8 Billion 25.93 Billion 23.5 Billion 22.79 Billion 24.91 Billion 18.53 Billion
Cash And Short Term Investments 14.11 Billion 16.92 Billion 15.79 Billion 16.43 Billion 19.1 Billion 13.02 Billion
Cash and Cash Equivalents 9.45 Billion 8.65 Billion 9.59 Billion 10.62 Billion 10.63 Billion 6.23 Billion
Short Term Investments 4.66 Billion 8.26 Billion 6.19 Billion 5.8 Billion 8.47 Billion 6.78 Billion
Net Receivables 4.51 Billion 4.64 Billion 4.28 Billion 2.91 Billion 2.71 Billion 2.92 Billion
Inventory 1.99 Billion 2.32 Billion 1.93 Billion 1.88 Billion 1.65 Billion 1.2 Billion
Other Current Assets 7.84 Billion 6.89 Billion 6.14 Billion 5.78 Billion 3.01 Billion 3.38 Billion
Total Non-Current Assets 39.79 Billion 38.12 Billion 37.04 Billion 24.41 Billion 33.38 Billion 31.24 Billion
Net PPE 9.91 Billion 9.25 Billion 8.51 Billion 7.15 Billion 6.97 Billion 7.02 Billion
Good Will And Intangible Assets 2.9 Billion 1.91 Billion 1.71 Billion 2.24 Billion 22.83 Billion 22.24 Billion
Good Will 680.45 Million 662.61 Million 647.93 Million 88.92 Million 13.89 Billion 13.89 Billion
Intangible Assets 2.22 Billion 1.25 Billion 1.06 Billion 2.15 Billion 8.93 Billion 8.34 Billion
Long-Term Investments 25.81 Billion 16.96 Billion 18.97 Billion 5.09 Billion -6.45 Billion -5.71 Billion
Tax Assets 567.01 Million 505.14 Million 334.86 Million 463.36 Million 580.94 Million 470.55 Million
Other Non Current Assets 592.01 Million 9.49 Billion 7.5 Billion 9.44 Billion 9.45 Billion 7.21 Billion
Other Assets - - - - - -
Total Liabilities 25.43 Billion 26.12 Billion 22.81 Billion 24.79 Billion 18.01 Billion 12.23 Billion
Total Current Liabilities 22.6 Billion 20.15 Billion 15.34 Billion 10.94 Billion 8.12 Billion 9.66 Billion
Account Payables 1.33 Billion 1.63 Billion 1.69 Billion 1.94 Billion 1.8 Billion 1.83 Billion
Tax Payables 516.01 Million 330.88 Million 343.65 Million 266.13 Million 319.23 Million 414.65 Million
Short Term Debt 11.2 Billion 9.72 Billion 6.58 Billion 1.58 Billion 689.82 Million 2.9 Billion
Deferred Revenue 10.05 Billion - - - - -
Other Current Liabilities 12.19 Million 8.78 Billion 7.06 Billion 7.41 Billion 5.62 Billion 4.93 Billion
Total Non Current Liabilities 2.82 Billion 5.97 Billion 7.46 Billion 13.84 Billion 9.89 Billion 2.56 Billion
Long-Term Debt 1.37 Billion 4.25 Billion 5.53 Billion 12.62 Billion 7.92 Billion 507.06 Million
Deferred Revenue Non Current 548.27 Million 749.07 Million 674.45 Million 608.2 Million 480.65 Million 532.94 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 125.46 Million 131.07 Million 380.78 Million 439.18 Million - -
Other Liabilities - - - - - -
Total Equity 38.16 Billion 37.94 Billion 37.72 Billion 22.41 Billion 40.28 Billion 37.54 Billion
Stock Holders Equity 30.47 Billion 29.74 Billion 30.29 Billion 16.74 Billion 31.11 Billion 29.21 Billion
Common Stock 414.61 Million 414.89 Million 415.44 Million 415.89 Million 278.45 Million 278.84 Million
Retained Earnings 23.64 Billion 23.06 Billion 23.07 Billion 13.6 Billion 11.95 Billion 16.81 Billion
Accumulated other comprehensive income 31.82 Billion -10.07 Billion -9.22 Billion -9.49 Billion -9.83 Billion -462.85 Million
Common Stock Equity 30.47 Billion 29.74 Billion 30.29 Billion 16.74 Billion 31.11 Billion 29.21 Billion
Capital Lease Obligation 369.88 Million 384.69 Million 384.42 Million 293.56 Million 64.34 Million 81.75 Million
Total Investments 25.81 Billion 25.22 Billion 25.16 Billion 10.9 Billion 2.01 Billion 1.06 Billion
Total Debt 12.58 Billion 13.98 Billion 12.11 Billion 14.2 Billion 8.61 Billion 3.41 Billion
Net Debt 3.12 Billion 5.32 Billion 2.51 Billion 3.58 Billion -2.01 Billion -2.82 Billion

Balance Sheet Charts